Literature DB >> 22948316

Evaluation of postoperative nephrolithiasis and renal dysfunction in gastric cancer patients.

Hiroki Shimizu1, Daisuke Ichikawa, Keiichi Tamagaki, Shuhei Komatsu, Takeshi Kubota, Kazuma Okamoto, Atsushi Shiozaki, Hitoshi Fujiwara, Noriyoshi Ota, Eigo Otsuji.   

Abstract

BACKGROUND: Roux-en-Y (R-Y) gastric bypass, also known as bariatric surgery, sometimes causes postoperative hyperoxaluria and subsequent oxalate nephrolithiasis in obese patients. In this study, we retrospectively investigated the frequency of occurrence of nephrolithiasis and renal dysfunction in postoperative gastric cancer patients with respect to the surgical procedures employed.
METHODS: Two hundred and twenty-six consecutive gastric cancer patients, who underwent distal gastrectomy with Billroth-I reconstruction (DGBI, 60 patients), distal gastrectomy with R-Y reconstruction (DGRY, 81 patients), and total gastrectomy with R-Y reconstruction (TGRY, 85 patients), were investigated for postoperative nephrolithiasis and renal dysfunction. We also examined the risk factors for postoperative nephrolithiasis in these patients with gastric cancer.
RESULTS: Nephrolithiasis was detected in 3 (5%), 7 (9%), and 21 (25%) patients in the DGBI, DGRY, and TGRY groups, respectively. There were significant differences in the frequency of nephrolithiasis between the DGBI and TGRY groups (p = 0.004), and between the DGRY and TGRY groups (p = 0.011), but there was no significant difference between the DGBI and DGRY groups. Multivariate logistic regression analysis revealed that gender and extent of gastrectomy were independent risk factors associated with nephrolithiasis. Renal dysfunction was found in 5 patients (6%) in the TGRY group, but was not found in either the DGBI or the DGRY group. Nephrolithiasis was detected in all these 5 patients, and a renal biopsy performed in one patient revealed the presence of intratubular calcium oxalate crystals with chronic tubulointerstitial nephritis.
CONCLUSION: Total gastrectomy with R-Y reconstruction was an independent predictive factor for nephrolithiasis in patients with gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22948316     DOI: 10.1007/s10120-012-0192-z

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  21 in total

1.  A prospective study of risk factors for nephrolithiasis after Roux-en-Y gastric bypass surgery.

Authors:  Alyssa M Park; Douglas W Storm; Brant R Fulmer; Christopher D Still; G Craig Wood; James E Hartle
Journal:  J Urol       Date:  2009-09-16       Impact factor: 7.450

2.  Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity.

Authors:  P R Schauer; S Ikramuddin; W Gourash; R Ramanathan; J Luketich
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

3.  Japanese classification of gastric carcinoma: 3rd English edition.

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

4.  Hyperoxaluria is a long-term consequence of Roux-en-Y Gastric bypass: a 2-year prospective longitudinal study.

Authors:  Branden G Duffey; Shaheen Alanee; Renato N Pedro; Bryan Hinck; Carly Kriedberg; Sayeed Ikramuddin; Todd Kellogg; Michelle Stessman; Angela Moeding; Manoj Monga
Journal:  J Am Coll Surg       Date:  2010-07       Impact factor: 6.113

5.  Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.

Authors:  Wayne K Nelson; Scott G Houghton; Dawn S Milliner; John C Lieske; Michael G Sarr
Journal:  Surg Obes Relat Dis       Date:  2005-08-26       Impact factor: 4.734

6.  Effect of bile salts and fatty acids on the colonic absorption of oxalate.

Authors:  J W Dobbins; H J Binder
Journal:  Gastroenterology       Date:  1976-06       Impact factor: 22.682

7.  Healthcare utilization and outcomes after bariatric surgery.

Authors:  William E Encinosa; Didem M Bernard; Chi-Chang Chen; Claudia A Steiner
Journal:  Med Care       Date:  2006-08       Impact factor: 2.983

8.  Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery.

Authors:  Naim M Maalouf; Prasanthi Tondapu; Eve S Guth; Edward H Livingston; Khashayar Sakhaee
Journal:  J Urol       Date:  2010-01-21       Impact factor: 7.450

9.  Effect of gastric bypass surgery on kidney stone disease.

Authors:  Brian R Matlaga; Andrew D Shore; Thomas Magnuson; Jeanne M Clark; Roger Johns; Martin A Makary
Journal:  J Urol       Date:  2009-04-16       Impact factor: 7.450

10.  Prevalence of hyperoxaluria after bariatric surgery.

Authors:  Bhavin N Patel; Corey M Passman; Adolfo Fernandez; John R Asplin; Fredric L Coe; Sam C Kim; James E Lingeman; Dean G Assimos
Journal:  J Urol       Date:  2008-11-14       Impact factor: 7.450

View more
  6 in total

Review 1.  Kidney stone risk following modern bariatric surgery.

Authors:  Ricardo D Gonzalez; Benjamin K Canales
Journal:  Curr Urol Rep       Date:  2014-05       Impact factor: 3.092

Review 2.  Kidney Stones After Bariatric Surgery: Risk Assessment and Mitigation.

Authors:  Pedro Mario Espino-Grosso; Benjamin Kirk Canales
Journal:  Bariatr Surg Pract Patient Care       Date:  2017-03-01       Impact factor: 0.607

Review 3.  Kidney stone incidence and metabolic urinary changes after modern bariatric surgery: review of clinical studies, experimental models, and prevention strategies.

Authors:  Benjamin K Canales; Marguerite Hatch
Journal:  Surg Obes Relat Dis       Date:  2014-04-15       Impact factor: 4.734

4.  Association of Kidney Stone Disease (KSD) with Primary Gastrointestinal Surgery: a Systematic Review over Last 2 Decades.

Authors:  Y Premakumar; N Gadiyar; B M Zeeshan Hameed; D Veneziano; B K Somani
Journal:  Curr Urol Rep       Date:  2021-05-24       Impact factor: 3.092

5.  Kidney stone risk following Roux-en-Y gastric bypass surgery.

Authors:  Benjamin K Canales; Ricardo D Gonzalez
Journal:  Transl Androl Urol       Date:  2014-09-01

6.  Urolithiasis in inflammatory bowel disease and bariatric surgery.

Authors:  Agapios Gkentzis; Michael Kimuli; Jon Cartledge; Olivier Traxer; Chandra Shekhar Biyani
Journal:  World J Nephrol       Date:  2016-11-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.